Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors.
作者信息
Hope Thomas A, Bergsland Emily K, Bozkurt Murat Fani, Graham Michael, Heaney Anthony P, Herrmann Ken, Howe James R, Kulke Matthew H, Kunz Pamela L, Mailman Josh, May Lawrence, Metz David C, Millo Corina, O'Dorisio Sue, Reidy-Lagunes Diane L, Soulen Michael C, Strosberg Jonathan R
机构信息
Society of Nuclear Medicine and Molecular Imaging, Reston, Virginia
American College of Radiology, Reston, Virginia.
出版信息
J Nucl Med. 2018 Jan;59(1):66-74. doi: 10.2967/jnumed.117.202275. Epub 2017 Oct 12.
Abstract
摘要
相似文献
1
Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors.神经内分泌肿瘤中生长抑素受体PET成像的合理使用标准
J Nucl Med. 2018 Jan;59(1):66-74. doi: 10.2967/jnumed.117.202275. Epub 2017 Oct 12.
2
High management impact of Ga-68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours.Ga-68 DOTATATE（镓肽）PET/CT对神经内分泌肿瘤及其他表达生长抑素的肿瘤成像具有较高的管理影响。
J Med Imaging Radiat Oncol. 2012 Feb;56(1):40-7. doi: 10.1111/j.1754-9485.2011.02327.x.
3
Somatostatin receptor imaging in patients with neuroendocrine tumors: not only SPECT?神经内分泌肿瘤患者的生长抑素受体显像：难道只能用单光子发射计算机断层扫描（SPECT）吗？
J Nucl Med. 2007 Apr;48(4):498-500. doi: 10.2967/jnumed.106.038653.
4
PET tracers for somatostatin receptor imaging of neuroendocrine tumors: current status and review of the literature.用于神经内分泌肿瘤生长抑素受体成像的正电子发射断层显像（PET）示踪剂：现状及文献综述
Future Oncol. 2014 Nov;10(14):2259-77. doi: 10.2217/fon.14.139.
5
Masking effect of chronic pancreatitis in the interpretation of somatostatin receptor positron emission tomography in pancreatic neuroendocrine tumors.慢性胰腺炎在胰腺神经内分泌肿瘤生长抑素受体正电子发射断层扫描解读中的掩盖效应
Pancreas. 2013 May;42(4):726-8. doi: 10.1097/MPA.0b013e3182750ea0.
6
Exceptional increase in somatostatin receptor expression in pancreatic neuroendocrine tumour, visualised with (68)Ga-DOTATOC PET.用（68）Ga-DOTATOC PET显像发现胰腺神经内分泌肿瘤中生长抑素受体表达异常增加。
Eur J Nucl Med Mol Imaging. 2004 Mar;31(3):466. doi: 10.1007/s00259-003-1436-2. Epub 2004 Jan 17.
7
Gallium-68 somatostatin receptor PET/CT: is it time to replace (111)Indium DTPA octreotide for patients with neuroendocrine tumors?镓-68生长抑素受体PET/CT：对于神经内分泌肿瘤患者，是时候用它取代（111）铟喷曲肽了吗？
Endocrine. 2012 Aug;42(1):3-4. doi: 10.1007/s12020-012-9681-4.
8
PET Imaging of Neuroendocrine Tumors.神经内分泌肿瘤的正电子发射断层显像
Radiol Clin North Am. 2021 Sep;59(5):789-799. doi: 10.1016/j.rcl.2021.05.006.
9
Somatostatin receptor PET/CT in neuroendocrine tumours: update on systematic review and meta-analysis.生长抑素受体 PET/CT 在神经内分泌肿瘤中的应用：系统评价和荟萃分析的更新。
Eur J Nucl Med Mol Imaging. 2013 Oct;40(11):1770-80. doi: 10.1007/s00259-013-2482-z. Epub 2013 Jul 20.
10
The continuing evolution of somatostatin receptor imaging in neuroendocrine tumours.神经内分泌肿瘤中生长抑素受体显像的持续发展
Nucl Med Commun. 2011 Mar;32(3):163-7. doi: 10.1097/MNM.0b013e3283436894.
引用本文的文献
1
Atypical Presentation of Pulmonary Carcinoid Tumor With Pleural Involvement: Diagnostic and Surgical Challenges.伴有胸膜受累的肺类癌肿瘤的非典型表现：诊断与手术挑战
Cureus. 2025 Jul 13;17(7):e87822. doi: 10.7759/cureus.87822. eCollection 2025 Jul.
2
A head-to-head prospective comparative analysis of Ga-DOTATATE PET/CT and I-MIBG SPECT/CT in central nervous system metastases of neuroblastoma and ganglioneuroblastoma.镓[Ga] DOTATATE正电子发射断层显像/计算机断层扫描（PET/CT）与碘[I]间碘苄胍单光子发射计算机断层扫描/计算机断层扫描（I-MIBG SPECT/CT）在神经母细胞瘤和神经节神经母细胞瘤中枢神经系统转移中的前瞻性对比分析
Eur J Nucl Med Mol Imaging. 2025 Jul 10. doi: 10.1007/s00259-025-07440-7.
3
Recent Clinical and Molecular Advances in the Management of Thymic Carcinoids: A Comprehensive Review.胸腺类癌治疗的近期临床与分子进展：全面综述
Cancers (Basel). 2025 Jun 13;17(12):1975. doi: 10.3390/cancers17121975.
4
Somatostatin Receptor Expression of Gastroenteropancreatic Neuroendocrine Tumors: A Comprehensive Analysis in the Era of Somatostatin Receptor PET Imaging.胃肠胰神经内分泌肿瘤的生长抑素受体表达：生长抑素受体PET成像时代的综合分析
Cancers (Basel). 2025 Jun 11;17(12):1937. doi: 10.3390/cancers17121937.
5
Neuroendocrine tumor of the duodenojejunal flexure: Role of Ga-DOTA-NOC PET-CT and oncologic implications of nodal metastasis-A case report.十二指肠空肠曲神经内分泌肿瘤：镓-多胺基多羧基大环配体-奥曲肽正电子发射断层扫描-计算机断层扫描的作用及淋巴结转移的肿瘤学意义——病例报告
Int J Surg Case Rep. 2025 Aug;133:111556. doi: 10.1016/j.ijscr.2025.111556. Epub 2025 Jun 22.
6
Appropriate use of tissue sampling and somatostatin receptor PET imaging in the diagnosis of pancreatic neuroendocrine tumors: results of an International Delphi Consensus.组织采样和生长抑素受体PET成像在胰腺神经内分泌肿瘤诊断中的合理应用：一项国际德尔菲共识的结果
Surg Endosc. 2025 May 2. doi: 10.1007/s00464-025-11667-8.
7
Prediction of lesion-based response to PRRT using baseline somatostatin receptor PET.使用基线生长抑素受体PET预测基于病灶的PRRT反应。
Front Med (Lausanne). 2025 Mar 14;12:1523862. doi: 10.3389/fmed.2025.1523862. eCollection 2025.
8
Research process of PET tracers for neuroendocrine tumors diagnosis.用于神经内分泌肿瘤诊断的正电子发射断层显像（PET）示踪剂的研究过程。
Am J Nucl Med Mol Imaging. 2025 Feb 25;15(1):1-14. doi: 10.62347/JXLY1661. eCollection 2025.
9
Ga-DOTATATE PET/CT in the Initial Staging of Well-Differentiated Gastroenteropancreatic and Non-Gastroenteropancreatic Neuroendocrine Tumors: Results of a Prospective Registry.镓-多柔比星PET/CT在高分化胃肠胰和非胃肠胰神经内分泌肿瘤初始分期中的应用：一项前瞻性注册研究结果
Cancers (Basel). 2025 Jan 27;17(3):434. doi: 10.3390/cancers17030434.
10
A Reassessment of the Clinical Utility of Ga-DOTATATE PET/CT in Patients With Gastroenteropancreatic Neuroendocrine Tumors.镓- DOTATATE PET/CT在胃肠胰神经内分泌肿瘤患者中的临床应用重新评估
J Surg Oncol. 2025 Jun;131(7):1336-1342. doi: 10.1002/jso.28061. Epub 2025 Jan 5.
本文引用的文献
1
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.美国神经内分泌肿瘤患者的发病率、患病率和生存结局趋势。
JAMA Oncol. 2017 Oct 1;3(10):1335-1342. doi: 10.1001/jamaoncol.2017.0589.
2
Evaluation of Ga-DOTATOC PET/MRI for whole-body staging of neuroendocrine tumours in comparison with Ga-DOTATOC PET/CT.戈舍瑞林 PET/MRI 全身分期与 Ga-DOTATOC PET/CT 比较在神经内分泌肿瘤中的应用评估。
Eur Radiol. 2017 Oct;27(10):4091-4099. doi: 10.1007/s00330-017-4803-2. Epub 2017 Apr 24.
3
Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance.双生长抑素受体/氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描成像在转移性神经内分泌肿瘤中的应用：一种具有预后意义的新型分级方案的提议
Theranostics. 2017 Mar 1;7(5):1149-1158. doi: 10.7150/thno.18068. eCollection 2017.
4
Ga-DOTATOC Imaging of Neuroendocrine Tumors: A Systematic Review and Metaanalysis.神经内分泌肿瘤的镓- DOTATOC成像：系统评价与荟萃分析
J Nucl Med. 2017 Sep;58(9):1452-1458. doi: 10.2967/jnumed.117.191197. Epub 2017 Mar 9.
5
Localization of Unknown Primary Site with Ga-DOTATOC PET/CT in Patients with Metastatic Neuroendocrine Tumor.镓- DOTATOC PET/CT在转移性神经内分泌肿瘤患者中对未知原发部位的定位
J Nucl Med. 2017 Jul;58(7):1054-1057. doi: 10.2967/jnumed.116.180984. Epub 2017 Feb 2.
6
The Impact of Somatostatin Receptor-Directed PET/CT on the Management of Patients with Neuroendocrine Tumor: A Systematic Review and Meta-Analysis.生长抑素受体导向的PET/CT对神经内分泌肿瘤患者管理的影响：一项系统评价和荟萃分析
J Nucl Med. 2017 May;58(5):756-761. doi: 10.2967/jnumed.116.185587. Epub 2017 Jan 12.
7
Phase 3 Trial of Lu-Dotatate for Midgut Neuroendocrine Tumors.镥[177Lu]奥曲肽治疗中肠神经内分泌肿瘤的3期试验
N Engl J Med. 2017 Jan 12;376(2):125-135. doi: 10.1056/NEJMoa1607427.
8
Treatment Response and Outcomes of Grade 3 Pancreatic Neuroendocrine Neoplasms Based on Morphology: Well Differentiated Versus Poorly Differentiated.基于形态学的3级胰腺神经内分泌肿瘤的治疗反应和结果：高分化与低分化
Pancreas. 2017 Mar;46(3):296-301. doi: 10.1097/MPA.0000000000000735.
9
68Ga-DOTATATE Compared with 111In-DTPA-Octreotide and Conventional Imaging for Pulmonary and Gastroenteropancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis.68Ga-DOTATATE与111In-DTPA-奥曲肽及传统成像技术用于肺和胃肠胰神经内分泌肿瘤的比较：一项系统评价和Meta分析
J Nucl Med. 2016 Jun;57(6):872-8. doi: 10.2967/jnumed.115.165803. Epub 2016 Jan 14.
10
Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites.68Ga-DOTATATE正电子发射断层扫描/计算机断层扫描用于检测胃肠胰神经内分泌肿瘤及未知原发部位的前瞻性研究
J Clin Oncol. 2016 Feb 20;34(6):588-96. doi: 10.1200/JCO.2015.64.0987. Epub 2015 Dec 28.
Zotero 插件